Vytrus Biotech has announced two new distribution agreements to commercialse its ingredient portfolio in India, Argentina, Paraguay, and Uruguay.
The biotech company has opted for the Indian territory to break into the cosmetic sector with its plant stem cell technology. India represents a key area of focus for Vytrus, with access to a market of nearly €12 billion in 2018 according to ICEX.
This agreement has been signed with Nano Tech Chemical Brothers, a young company with strong digital initiatives. They have also incorporated Dermasist, an independent applications laboratory and customer service center that focus its work on prototyping and custom formulations, solving problems, innovating new concepts, and helping startups develop their brands and products.
